Sara Boulanouar

Sara Boulanouar is a highly skilled scientist with extensive experience in analytical development, specializing in mRNA-based therapeutics and drug delivery systems. Currently serving as Senior Scientist II at Addition Therapeutics since April 2024, Sara previously held positions as Senior Scientist at Nutcracker Therapeutics, focusing on the development and characterization of analytical methods for mRNA therapeutics, and worked at Genentech as a Scientist in Small Molecule Pharmaceutical Sciences. Earlier roles at Thermo Fisher Scientific involved the development of analytical methods for various biological and food matrices, while academic experiences at ESPCI Paris and Universitat Rovira i Virgili included significant research in analytical chemistry and sample extraction techniques. Sara holds a PhD in Analytical Chemistry from Pierre and Marie Curie University and multiple degrees in chemistry and chromatographic techniques.